{"id":113990,"date":"2023-10-24T01:45:13","date_gmt":"2023-10-24T01:45:13","guid":{"rendered":"https:\/\/dailytalks.org\/?p=113990"},"modified":"2023-10-24T01:45:13","modified_gmt":"2023-10-24T01:45:13","slug":"pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=113990","title":{"rendered":"Pre-surgical immunotherapy improves outcomes for patients with operable lung cancer"},"content":{"rendered":"<p>Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy\u2014given before and after surgery\u2014significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC). Results from the Phase III CheckMate 77T study were presented today at the 2023 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center&#8230;<br \/><a href=\"https:\/\/medicalxpress.com\/news\/2023-10-pre-post-surgical-immunotherapy-outcomes-patients.html\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy\u2014given before and after surgery\u2014significantly improved event-free<\/p>\n","protected":false},"author":1,"featured_media":113991,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-113990","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europe"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/113990-pre-surgical-immunotherapy-improves-outcomes-for-patients-with-operable-lung-cancer.jpg",90,90,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=16\" rel=\"category\">Europe<\/a>","tag_info":"Europe","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/113990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=113990"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/113990\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/113991"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=113990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=113990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=113990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}